Michael Cola
2021
In 2021, Michael Cola earned a total compensation of $2.7M as Former Chief Executive Officer and former principal executive officer at Avalo Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $325,500 |
|---|---|
| Option Awards | $2,332,743 |
| Salary | $35,568 |
| Total | $2,693,811 |
Cola received $2.3M in option awards, accounting for 87% of the total pay in 2021.
Cola also received $325.5K in non-equity incentive plan and $35.6K in salary.
Rankings
In 2021, Michael Cola's compensation ranked 4,855th out of 12,412 executives tracked by ExecPay. In other words, Cola earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,855 out of 12,412 | 61st |
Division Manufacturing | 2,029 out of 5,498 | 63rd |
Major group Chemicals And Allied Products | 857 out of 2,374 | 64th |
Industry group Drugs | 767 out of 2,095 | 63rd |
Industry Pharmaceutical Preparations | 548 out of 1,542 | 65th |
Source: SEC filing on April 25, 2022.
Cola's colleagues
We found four more compensation records of executives who worked with Michael Cola at Avalo Therapeutics in 2021.